471 – 480 of 526
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Evaluation of Plasma A beta as Predictor of Alzheimer's Disease in Older Individuals Without Dementia: A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.
(
- Contribution to journal › Article
-
Mark
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly.
(
- Contribution to journal › Article
-
Mark
Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum.
(
- Contribution to journal › Article
- 2011
-
Mark
Cerebrospinal Fluid Microglial Markers in Alzheimer's Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
(
- Contribution to journal › Article
-
Mark
Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Prediction of Alzheimer's Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article